US equities |
NVDA $239.75 ▲+2.48% SPCX $169.48 ▲+6.62% MU $1,061.25 ▼-1.27% TSLA $380.82 ▲+2.76% SNDK $1,693.37 ▼-1.55% MSFT $528.29 ▲+2.08% INTC $116.36 ▼-2.49% META $742.89 ▲+2.03%
FinancialContent

Articles published by Cellares Corp

News headline image
Autolus Therapeutics to Evaluate Automated Manufacturing of AUCATZYL® (obe-cel) on the Cellares Cell ShuttleTM Platform
From Cellares Corp
Via Business Wire
Tickers AUTL